Skip to content

Reducing 30-Day Sepsis Readmissions: Impact of a Post Discharge Education Program

Reducing 30-Day Sepsis Readmissions: Impact of a Post Discharge Education Program

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05602896
Enrollment
0
Registered
2022-11-02
Start date
2024-03-31
Completion date
2025-07-31
Last updated
2024-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Keywords

sepsis, education, cancer

Brief summary

This study will advance the knowledge in the field by determining the effectiveness of discharge education regarding prevention of a new infection which is the highest cause of readmission for sepsis patient. In evaluating the impact care teams will develop a clearer link between specific home-based education interventions and infection prevention. This study is an exploratory study designed to identify whether patient education through an innovative teaching method can have an impact on readmissions. This study may the first of several based on findings from this initial, exploratory study.

Interventions

The education program has been reviewed and approved by BJH Center for Practice Excellence

Sponsors

BJC HealthCare
CollaboratorOTHER
Viven Health
CollaboratorUNKNOWN
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Oncology patients discharged to home following a diagnosis of sepsis, severe sepsis or septic shock * Patient must have a mobile phone/device * English speakers * Age range 18 - 85 years

Exclusion criteria

* Less than 18 years of age and older than 85 years of age * No mobile phone/device * Non-English speaking * No diagnosis of sepsis, severe sepsis, or septic shock * Non-Oncology patient

Design outcomes

Primary

MeasureTime frame
Readmission rates4 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026